Clinical Trial Update: Mifepristone and Misoprostol for Fetal Demise [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update indicating completion of a study evaluating the combination of mifepristone and misoprostol for fetal demise-related conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anembryonic Pregnancy
• Gestational Abnormality
• Intrauterine Fetal Demise

Drugs mentioned

• MISOPROSTOL (Misoprostol)
• Mifepristone (mifepristone)

Snippet

Sponsor: University of Pittsburgh | Conditions: Anembryonic Pregnancy, Gestation Abnormality | Phase 4 | Status: COMPLETED